Impact of ADHD Medication on College Admissions Test Performance
Research Overview
Swedish medical researchers have found that children diagnosed with ADHD who take medication perform better on college and university admissions tests compared to those whose symptoms remain untreated. While ADHD medications are generally recognized for their effectiveness in reducing symptoms, there has been limited research into their broader impact on patients’ lives. A team from the Karolinska Institute in Stockholm sought to address this gap through a comprehensive cohort study across Sweden.
Study Methodology
The researchers aimed to understand whether treating ADHD symptoms benefits children beyond their daily routines, specifically in terms of admissions tests. In a significant study published in JAMA Psychiatry in 2017, they analyzed medical records and test scores from 61,640 adolescents and young adults diagnosed with ADHD between 2006 and 2013. The study focused on the effects of ADHD medication on scores from the Swedish Scholastic Aptitude Test (SweSAT), the national entrance exam for universities and colleges.
To conduct the analysis, the researchers utilized data from Swedish national registers and compared treatment records with SweSAT results. They employed a ‘within-patient’ design, contrasting test scores of the same individuals during periods of medication use against periods without medication.
Key Findings
The findings revealed that individuals with ADHD who were on medication tended to take the SweSAT fewer times than their unmedicated peers, but at an older average age (20.6 years vs. 22.1 years). Medicated students scored an average of 10 points higher on the SweSAT compared to their unmedicated counterparts. Furthermore, when comparing individual scores during medicated versus unmedicated periods, a notable increase of 4.8 points was observed.
These results indicate that children taking ADHD medication as prescribed achieve better outcomes in college admissions tests compared to those not on medication. Additionally, those who retook the exam while on medication performed significantly better than during previous attempts, suggesting that the medication not only aids in managing symptoms but also enhances performance.
Validity and Limitations of the Study
The study underwent rigorous statistical analysis, reinforcing its scientific validity. However, certain limitations were noted. Many ADHD patients typically struggle with adherence to medication regimens, which could mean that some individuals prescribed medication were not consistently using it. This non-adherence might obscure the full benefits of ADHD medications on college admissions test performance, indicating that the actual effect size could be larger than reported.
The study primarily focused on students pursuing higher education, leaving uncertainty about the applicability of the results to those entering vocational training. Additionally, the ‘within-patient’ design did not account for individuals who only took the test once, nor did it address the potential impact of coexisting learning disabilities on test outcomes.
Long-term Implications for Children with ADHD
The association between ADHD medication use and improved performance on higher education entrance tests underscores the potential long-term advantages for children whose ADHD is treated. Medical professionals should consider these findings along with the existing risks and benefits of ADHD treatments when making prescribing decisions.
ADHD is a prevalent condition affecting both children and adults, often hindering academic achievement. The core symptoms of ADHD—such as inattention, impulsivity, and hyperactivity—pose challenges in educational environments, resulting in lower grades and reduced educational attainment compared to peers without ADHD. The implications of these academic disadvantages can extend throughout an individual’s life.
In conclusion, the authors of the study emphasize that the significant impact of ADHD medication on college admissions test scores should be taken into account alongside the risks and benefits when determining appropriate treatment strategies for ADHD.
References
Lu Y, Sjölander A, Cederlöf M, et al. Association Between Medication Use and Performance on Higher Education Entrance Tests in Individuals With Attention-Deficit/Hyperactivity Disorder. JAMA Psychiatry. 2017;74(8):815-822. doi:10.1001/jamapsychiatry.2017.1472.